Adenovirus Hepatocyte Growth Factor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adenovirus Hepatocyte Growth Factor, covering 2013-08-20 to 2013-08-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease [Phase 1, Phase 2]